Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting
Information source: Centers for Disease Control and Prevention
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Mycoplasma Pneumoniae
Intervention: Doxycycline treatment (Drug)
Phase: N/A
Status: Completed
Sponsored by: Centers for Disease Control and Prevention Official(s) and/or principal investigator(s):
Julia A Schillinger, MD, Principal Investigator, Affiliation: Centers for Disease Control and Prevention
Summary
This study was designed to determine whether taking daily doxycycline during an outbreak of
Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing
disease transmission during an outbreak. Doxycycline is a treatment for Mycoplasma
pneumoniae, but it is not certain that the drug could prevent disease if used
prophylactically.
Clinical Details
Official title: A Double-Blind, Randomized Placebo-Controlled Trial of Doxycycline for Chemoprophylaxis in the Setting of an Outbreak of Mycoplasma Pneumoniae
Study design: Randomized, Double-Blind, Placebo Control, Parallel Assignment
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Working at hospital facility where outbreak of Mycoplasma pneumoniae occured
Exclusion Criteria:
- Pregnant, on antiseizure medications, allergic to macrolide antibiotics
Locations and Contacts
Additional Information
Starting date: January 1994
Ending date: April 1994
Last updated: September 13, 2005
|
